abstract |
The present invention provides a diastereomeric peptide derived from the T cell receptor alpha transmembrane region, and the lipophilic conjugate, wherein the peptide and conjugate are effective in the prevention and treatment of T cell mediated inflammatory diseases. The present invention provides pharmaceutical compositions comprising these diastereomeric peptides and conjugates and their use to treat inflammatory diseases, autoimmunity and graft rejection. |